All articles by  

  1. M&As this week: JW Pharmaceutical, Lonza, Karo Intressenter

    JW Pharmaceutical has acquired a 25% stake in Argonaut Therapeutics through a $2.6m investment. This move makes JW Pharmaceutical the second…
    Read More…

    2 Nov
  2. M&As this week: Datinvest, Shanghai Pharmaceuticals, Sunrise Bright Investment

    Canadian company Datinvest International (Datinvest) has signed an agreement to purchase all the outstanding shares and share capital issued by…
    Read More…

    25 May
  3. Deals this week: Cipla, Takeda Pharmaceutical, Cadila Healthcare

    Indian pharmaceutical company Cipla plans to issue non-convertible debentures or bonds through a public offering or a private placement to…
    Read More…

    25 May
  4. M&As this week: Eli Lilly, Fujifilm Holdings, Canopy Growth

    US-based healthcare company Eli Lilly and Company has agreed to acquire AurKa Pharma Inc. Eli Lilly will purchase all shares of…
    Read More…

    18 May
  5. Deals this week: GlaxoSmithKline, Ligand, Catalent Pharma Solutions

    GlaxoSmithKline Plc (GSK) has issued 1.25% international bonds due May 2026 in a public offering to raise ‎€1bn ($1.19bn). The…
    Read More…

    18 May
  6. M&As this week: Strides Shasun, Takeda Pharmaceutical, Eli Lilly

    Indian bio-pharmaceuticals developer Strides Shasun has signed an agreement with Apotex to merge with the latter’s Australian subsidiary, Apotex. A…
    Read More…

    11 May
  7. Deals this week: MannKind, XtalPi, Ascendia Pharmaceuticals

    Indian biopharmaceutical company MannKind has agreed to sign a marketing and distribution agreement with Cipla for the inhaled insulin drug,…
    Read More…

    11 May
  8. Deals this week: IntelGenx, Oasmia Pharmaceutical, Karo Pharma

    Canadian oral drug delivery company IntelGenx Technologies plans to issue 300 units priced at $10,000 a unit in a private…
    Read More…

    4 May
  9. M&As this week: United Therapeutics, Par Formulations, Endo Ventures

    United Therapeutics Corporation has agreed to acquire SteadyMed for $216m. United Therapeutics will purchase SteadyMed for $4.46 a share in…
    Read More…

    4 May
  10. Deals this week: CTD Holdings, Peptron, Hemispherx Biopharma

    US-based biotechnology company CTD Holdings has completed issuing 20,000 units of series B convertible preferred stock for the development of its…
    Read More…

    27 Apr
Close
Close
Close

Go Top